Evidence map›Paper›PMID 36273238›Full record

ArticleScientific reports2022

(Pre)diabetes, glycemia, and daily glucose variability are associated with retinal nerve fiber layer thickness in The Maastricht Study.

Frank C T van der Heide, Yuri D Foreman, Iris W M Franken, Ronald M A Henry, Abraham A Kroon, Pieter C Dagnelie, Simone J P M Eussen, Tos T J M Berendschot, Jan S A G Schouten, Carroll A B Webers and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Frank C T van der Heide *CARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands. frank.vander.heide@mumc.nl.ORCID 0000-0002-8085-0245
Yuri D Foreman *CARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0002-0035-1586
Iris W M FrankenCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.
Ronald M A HenryCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0002-0860-3485
Abraham A KroonCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0001-7750-8249
Pieter C DagnelieCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0003-1767-8814
Simone J P M EussenCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0003-0559-6838
Tos T J M BerendschotUniversity Eye Clinic Maastricht, MUMC+, Maastricht, The Netherlands.ORCID 0000-0002-8101-939X
Jan S A G SchoutenUniversity Eye Clinic Maastricht, MUMC+, Maastricht, The Netherlands.ORCID 0000-0001-8343-4442
Carroll A B WebersUniversity Eye Clinic Maastricht, MUMC+, Maastricht, The Netherlands.ORCID 0000-0001-5605-740X
Miranda T SchramCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0001-8113-7604
Carla J H van der KallenCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0003-1468-8793
Marleen M J van GreevenbroekCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0002-2989-1631
Anke WesseliusDepartment of Complex Genetics and Epidemiology, NUTRIM School for Nutrition and Translational Research in Metabolism, UM, Maastricht, The Netherlands.ORCID 0000-0003-4474-9665
Casper G SchalkwijkCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0003-0190-2690
Nicolaas C SchaperCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0002-2128-8029
Martijn C G J BrouwersCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0002-8229-3331
Coen D A StehouwerCARIM School for Cardiovascular Diseases, Maastricht University (UM), Maastricht, The Netherlands.ORCID 0000-0001-8752-3223
Maastricht University Medical Centre · NLMaastricht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinopathy and neuropathy in type 2 diabetes are preceded by retinal nerve fibre layer (RNFL) thinning, an index of neurodegeneration. We investigated whether glucose metabolism status (GMS), measures of glycaemia, and daily glucose variability (GV) are associated with RNFL thickness over the entire range of glucose tolerance. We used cross-sectional data from The Maastricht Study (up to 5455 participants, 48.9% men, mean age 59.5 years and 22.7% with type 2 diabetes) to investigate the associations of GMS, measures of glycaemia (fasting plasma glucose [FPG], 2-h post-load glucose [2-h PG], HbA1c, advanced glycation endproducts [AGEs] assessed as skin autofluorescence [SAF]) and indices of daily GV (incremental glucose peak [IGP] and continuous glucose monitoring [CGM]-assessed standard deviation [SD]) with mean RNFL thickness. We used linear regression analyses and, for GMS, P for trend analyses. We adjusted associations for demographic, cardiovascular risk and lifestyle factors, and, only for measures of GV, for indices of mean glycaemia. After full adjustment, type 2 diabetes and prediabetes (versus normal glucose metabolism) were associated with lower RNFL thickness (standardized beta [95% CI], respectively - 0.16 [- 0.25; - 0.08]; - 0.05 [- 0.13;  0.03]; P

Indexed as

Diabetes Mellitus, Type 2Prediabetic StateRetinal DiseasesBlood GlucoseBlood Glucose Self-MonitoringCross-Sectional StudiesFemaleGlucoseGlycated HemoglobinGlycation End Products, AdvancedHumansMaleMiddle AgedNerve FibersTomography, Optical CoherenceBlood GlucoseGlucoseGlycated HemoglobinGlycation End Products, Advanced

Identifiers

PMID36273238
PMCPMC9587985
OpenAlexW4307138258

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.